Allergy related disorders among 2-yrs olds in a general population. The PACT Study

Ingeborg Smidesang1, Marit Saunes, Ola Storrø

  • 1Department of Public Health and General Practice, Faculty of Medicine, Norwegian University of Science and Technology, Trondheim, Norway.

Insights

Two in five young children have allergy-related disorders, but less than 10% show positive allergy tests. Atopic dermatitis (AD) and allergic rhinoconjunctivitis (ARC) are common, with boys more affected than girls.

Area of Science:

  • Pediatrics
  • Allergology
  • Epidemiology

Background:

  • Allergic disorders are a significant public health concern, particularly in developed nations.
  • There is a lack of population-based research on early childhood allergies.
  • Understanding prevalence and risk factors in toddlers is crucial for early intervention.

Purpose of the Study:

  • To determine the prevalence and distribution of allergy-related disorders in 2-year-old children.
  • To investigate gender differences in allergy prevalence and sensitization.
  • To explore the association between allergy-related disorders and allergic sensitization.

Main Methods:

  • A population-based study involving 4783 children aged 2 years.
  • Parental questionnaires collected data on allergy symptoms and diagnoses.
  • Skin prick tests (SPT) were performed on a randomly selected subsample (n=390).

Main Results:

  • Prevalence: Wheeze (26%), doctor-diagnosed asthma (7.0%), atopic dermatitis (AD) (17%), allergic rhinoconjunctivitis (ARC) (3%).
  • Sensitization: 59% of tested children had a positive allergy test; only 8% of SPTs were positive.
  • Associations: Children with AD showed high sensitization rates; ARC was linked to other allergies (70%). Boys had higher rates of allergy-related disorders and positive tests.

Conclusions:

  • Two in five children experienced allergy-related disorders, yet less than 10% had positive SPTs.
  • Existing allergic disorders, particularly ARC, increase the risk of developing others.
  • Atopic dermatitis (AD) is strongly associated with positive allergy tests, and boys exhibit a higher predisposition to allergies.

Related Concept Videos

Allergic Reactions02:06

Allergic Reactions

Overview
Allergic Drug Reactions01:27

Allergic Drug Reactions

Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing numerous...
Asthma I: Introduction01:28

Asthma I: Introduction

Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
Allergic Reactions: Anaphylaxis01:30

Allergic Reactions: Anaphylaxis

Anaphylaxis is a severe, life-threatening hypersensitivity reaction mediated by Immunoglobulin E (IgE) antibodies. When IgE binds to allergens, it triggers the release of mediators– histamine, leukotrienes, and prostaglandins from mast cells and basophils. These mediators cause vasodilation, edema, and inflammation, leading to various symptoms.The primary allergens causing anaphylaxis include food items (e.g., peanuts, shellfish), drugs (e.g., penicillin, asparaginase, corticotropin, heparin),...
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include: